The penetration of the two components of imidazole 2-hydroxybenzoate (ITF 182), imidazole and salicylate, into inflamed sites induced by intrapleural injection of carrageenin in the rat and by a urate-cotton pellet implantation in the knee joint of the rabbit is studied. The results obtained show that the two components of the salt penetrate rapidly the inflamed sites and display different kinetic profiles: imidazole diffuses throughout inflamed and non-inflamed fluids without any specific localization, salicylate shows preferential localization in inflamed fluids and remains longer than imidazole.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Rapid and transient lymphocytopenia after i.v. administration of high doses of human recombinant erythropoietin.
Hematopathol Mol Hematol
February 1998
Department of Internal Medicine, University of Messina, Italy.
The effect of administration of human recombinant erythropoietin on leukocytic cells has been evaluated. In humans the administration of 20,000 U i.v.
View Article and Find Full Text PDFEffects of imidazole-salicylate on renal function and the diuretic action of furosemide in cirrhotic patients with ascites.
J Hepatol
September 1993
Istituto di Medicina Interna, Università di Milano, Italy.
Imidazole-salicylate is a non-steroidal anti-inflammatory drug with limited inhibitory effects on prostaglandin synthesis. The renal effects of this drug were investigated by a double-blind cross-over study in 10 patients with cirrhosis and ascites. Two therapeutic doses of imidazole-salicylate (750 mg each) were given at midnight and 08:00 h and 80 mg of furosemide were injected intravenously at 09:00 h.
View Article and Find Full Text PDFRenal effects of imidazole-2-hydroxybenzoate in patients with compensated liver cirrhosis.
Int J Clin Pharmacol Ther Toxicol
July 1992
Istituto di Medicina Interna, Università di Milano, Italy.
A double-blind crossover study versus placebo of the renal effects of the nonsteroidal anti-inflammatory drug imidazole 2-hydroxybenzoate was conducted in 10 patients with compensated liver cirrhosis. The administration of the drug (750 mg, t.i.
View Article and Find Full Text PDFBlood binding of selezen (imidazole salicylate) in man.
Int J Clin Pharmacol Ther Toxicol
June 1991
Laboratoire de pharmacologie UFR de Médecine de Paris XII, Créteil, France.
The interactions of selezen (imidazole salicylate) with human blood components were studied by equilibrium dialysis. These interactions were limited to the binding of salicylate to human serum albumin (HSA). The binding was saturable and involved several classes of binding sites with different association constants.
View Article and Find Full Text PDFDouble-blind randomized clinical trial on imidazole salicylate vs ibuprofen in osteoarthritis.
Int J Clin Pharmacol Ther Toxicol
May 1991
Department of Internal Medicine 2, Kaiser-Franz-Josef-Hospital, Vienna, Austria.
Imidazole salicylate (750 mg t.i.d.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!